These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12424431)

  • 1. HESX1 and Septo-Optic Dysplasia.
    Dattani MT; Robinson IC
    Rev Endocr Metab Disord; 2002 Dec; 3(4):289-300. PubMed ID: 12424431
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders.
    Brickman JM; Clements M; Tyrell R; McNay D; Woods K; Warner J; Stewart A; Beddington RS; Dattani M
    Development; 2001 Dec; 128(24):5189-99. PubMed ID: 11748154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hesx1 gene in midline cerebral defects.
    Antonini SR; Grecco Filho AS; Elias LL; Moreira AC; de Castro M
    J Pediatr; 2001 Nov; 139(5):754. PubMed ID: 11713462
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia.
    Cohen RN; Cohen LE; Botero D; Yu C; Sagar A; Jurkiewicz M; Radovick S
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4832-9. PubMed ID: 14557462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HESX1: a novel gene implicated in a familial form of septo-optic dysplasia.
    Dattani MT; Martinez-Barbera JP; Thomas PQ; Brickman JM; Gupta R; Wales JK; Hindmarsh PC; Beddington RS; Robinson IC
    Acta Paediatr Suppl; 1999 Dec; 88(433):49-54. PubMed ID: 10626545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic posterior pituitary lobe and periventricular heterotopia: cerebral malformations with the same underlying mechanism?
    Mitchell LA; Thomas PQ; Zacharin MR; Scheffer IE
    AJNR Am J Neuroradiol; 2002 Oct; 23(9):1475-81. PubMed ID: 12372734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural hypothalamic defects.
    Dattani M
    J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1423-4. PubMed ID: 12510996
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular genetics of septo-optic dysplasia.
    Dattani ML; Martinez-Barbera J; Thomas PQ; Brickman JM; Gupta R; Wales JK; Hindmarsh PC; Beddington RS; Robinson IC
    Horm Res; 2000; 53 Suppl 1():26-33. PubMed ID: 10895039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From panhypopituitarism to combined pituitary deficiencies: do we need the anterior pituitary?
    Carrière C; Gleiberman A; Lin CR; Rosenfeld MG
    Rev Endocr Metab Disord; 2004 Mar; 5(1):5-13. PubMed ID: 14966385
    [No Abstract]   [Full Text] [Related]  

  • 10. Septo-optic dysplasia and other midline defects: the role of transcription factors: HESX1 and beyond.
    McCabe MJ; Alatzoglou KS; Dattani MT
    Best Pract Res Clin Endocrinol Metab; 2011 Feb; 25(1):115-24. PubMed ID: 21396578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse.
    Dattani MT; Martinez-Barbera JP; Thomas PQ; Brickman JM; Gupta R; Mårtensson IL; Toresson H; Fox M; Wales JK; Hindmarsh PC; Krauss S; Beddington RS; Robinson IC
    Nat Genet; 1998 Jun; 19(2):125-33. PubMed ID: 9620767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Septo-optic dysplasia complex: a heterogeneous malformation syndrome.
    Polizzi A; Pavone P; Iannetti P; Manfré L; Ruggieri M
    Pediatr Neurol; 2006 Jan; 34(1):66-71. PubMed ID: 16376284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of mouse models carrying the I26T and R160C substitutions in the transcriptional repressor HESX1 as models for septo-optic dysplasia and hypopituitarism.
    Sajedi E; Gaston-Massuet C; Signore M; Andoniadou CL; Kelberman D; Castro S; Etchevers HC; Gerrelli D; Dattani MT; Martinez-Barbera JP
    Dis Model Mech; 2008; 1(4-5):241-54. PubMed ID: 19093031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of homeodomain transcription factors in heritable pituitary disease.
    Prince KL; Walvoord EC; Rhodes SJ
    Nat Rev Endocrinol; 2011 Jul; 7(12):727-37. PubMed ID: 21788968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel homozygous HESX1 mutation causes panhypopituitarism without midline defects and optic nerve anomalies.
    Durmaz B; Cogulu O; Dizdarer C; Stobbe H; Pfaeffle R; Ozkinay F
    J Pediatr Endocrinol Metab; 2011; 24(9-10):779-82. PubMed ID: 22145475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia.
    Thomas PQ; Dattani MT; Brickman JM; McNay D; Warne G; Zacharin M; Cameron F; Hurst J; Woods K; Dunger D; Stanhope R; Forrest S; Robinson IC; Beddington RS
    Hum Mol Genet; 2001 Jan; 10(1):39-45. PubMed ID: 11136712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sporadic heterozygous frameshift mutation of HESX1 causing pituitary and optic nerve hypoplasia and combined pituitary hormone deficiency in a Japanese patient.
    Tajima T; Hattorri T; Nakajima T; Okuhara K; Sato K; Abe S; Nakae J; Fujieda K
    J Clin Endocrinol Metab; 2003 Jan; 88(1):45-50. PubMed ID: 12519827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel human pathological mutations. Gene symbol: HESX1. Disease: septo-optic dysplasia.
    Mueller OT; Coovadia A
    Hum Genet; 2010 Apr; 127(4):478-9. PubMed ID: 21488242
    [No Abstract]   [Full Text] [Related]  

  • 19. Septo-optic-pituitary dysplasia.
    Humphreys P
    Handb Clin Neurol; 2008; 87():39-52. PubMed ID: 18809017
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of R53C mutation on the three-dimensional structure, stability, and DNA-binding properties of the human Hesx-1 homeodomain.
    de la Mata I; Garcia JL; González C; Menéndez M; Cañada J; Jiménez-Barbero J; Asensio JL
    Chembiochem; 2002 Aug; 3(8):726-40. PubMed ID: 12203971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.